Genertec Universal Medical (2666.HK) has been successfully selected into S&P Global’s Sustainability Yearbook (China Edition) for the first time and awarded the honor of "Industry's Best Progress Enterprise" for its outstanding performance in the environment, social responsibility, and governance (ESG) fields at the S&P Global Sustainable1 Forum and the launching ceremony of Sustainability Yearbook (China Edition) 2025 held in Shenzhen on May 13. As the first appearance of Universal Medical in this yearbook, this selection indicates that the company's long-term investment and remarkable achievements in the field of sustainable development have been highly recognized by global leading ESG rating agencies.

Since 2023, S&P Global has released the Sustainability Yearbook (China Edition) annually to identify and commend benchmark enterprises that have performed excellently and led the trend of sustainable development in various industries in China. The selection of this yearbook is mainly based on the results of the S&P Global 2024 Corporate Sustainability Assessment (CSA), comprehensively considering the absolute value of enterprises' CSA scores, industry rankings, and the gap from the industry's highest score. In 2025, more than 1,600 Chinese enterprises covering 60 industries were included in the selection scope, and only 164 were finally selected into the yearbook.

Previously, S&P Global released the results of Universal Medical's 2024 Corporate Sustainability Assessment: an ESG score of 61 and a CSA score of 59, ranking first among domestic peers (top 10% globally). Over the past three years, Universal Medical's ESG score has jumped from 19 to 61, and it is precisely because of this largest increase in the industry that the company was awarded the "Industry's Best Progress Enterprise". In addition, the company has been selected into CCTV's "China ESG Listed Companies Pioneer 100" list for two consecutive years, fully demonstrating that its outstanding performance in ESG practices has been recognized and affirmed by authoritative institutions at home and abroad.

In recent years, Universal Medical has given full play to its industry-finance integration advantages of "taking medical services as the core, financial services as the support, and health technology as the engine", and is committed to building a shared and win-win big health ecosystem, deeply integrating the social responsibility of state-owned central enterprises into the company's development overall situation. In terms of the environment, under the dual drive of "green finance" and "low-carbon medical care", Universal Medical has contributed to building an ecological civilization and an environment-friendly society; in terms of society, relying on medical public welfare scenarios, it has promoted health popularization, developed health technology, invested in rural revitalization, and created a unique medical service brand and a new model of high-quality medical services by central enterprises; in terms of governance, the company has improved its governance system, taken ESG as the highest standard of corporate governance, and laid a foundation for improving governance efficiency and practicing sustainable development.

In 2024, Universal Medical pioneered the proposal of a company-level ESG strategic system, fully integrating ESG governance into strategic management and daily operations, marking that the company's ESG construction has entered a new stage driven by internal strategy from the policy-driven stage of simply responding to regulatory requirements. Taking the construction of the management system, the improvement of professional ratings, the recognition of corporate value, and the publicity of information disclosure as the four key starting points, the company continues to promote the improvement of ESG construction levels, striving to build itself into a world-class medical and health industry group worthy of trust, so as to achieve the coordination between enterprise development and serving the people, the growth of employees, environmental sustainable development, and win-win with stakeholders.

Universal Medical became one of the first "ISSB International Sustainable Disclosure Standards First-Learning Partners" in China in 2023, learning in advance and integrating the framework and requirements of ISSB standards, and plans to further respond to the new climate disclosure rules of the Hong Kong Stock Exchange, identify climate-related risks and opportunities, and continuously improve climate strategy formulation and decision-making mechanisms. In response to the initiatives of regulatory agencies and following the international sustainable development trend, Universal Medical is committed to promoting the transformation of sustainable information from compliant disclosure to value creation and driving the leapfrog growth of listed companies in comprehensive value leadership.

In the future, Universal Medical will continue to practice the corporate mission of "leading a better life with technological progress and quality services", continue to deepen the ESG field, carry out high-quality ESG practices, help the sustainable development of the economy, environment, and society, and contribute the strength of central enterprises to building a Chinese-style ESG system and improving China's influence and voice in the global ESG system.